Ophthalmic Femtosecond Lasers Market was valued at USD 2,042.1 million in 2018 and is expected to grow at a CAGR of 7.1% during the forecast period, 2021–2026.

Ophthalmic Femtosecond Lasers Market

Femtosecond lasers are ultrafast, ultrashort lasers that emit light pulses at a rate of 10-15 times per second. By employing the passive mode locking technique, brief pulses can be generated. This method is used to create light pulses with a very short duration (such as for picosecond or femtosecond durations). Ophthalmic Femtosecond Lasers Market are popular among ophthalmologists because they enable to simplify and avoid difficult open surgery procedures. The most prevalent application of this laser is flap formation in laser in situ keratomileusis (LASIK). Other corneal refractive operations, cataract surgery, including lamellar and full thickness corneal transplants can all be performed with it. The femtosecond laser produces tiny, homogeneous flaps that improve the flaps' stability, safety, and precision.

According to the Centers for Disease Control and Prevention (CDC), cataract is the most common cause of blindness in the 116 countries covered by the World Health Organization's (WHO) Program for the Prevention of Blindness. In 2014, nearly 42 million people were affected by severe vision loss, with cataract being the primary cause in 17 million of these cases. In the same year, cataract was the leading cause of blindness in 43.6 percent of nation reports.

In the United States, there is a potential target population.

According to the Centers for Disease Control and Prevention, over 20.5 million persons in the United States suffered from cataracts in 2015, the majority of whom were over the age of 40. An increasing incidence rate of cataract and a growing geriatric population are two major drivers for the Ophthalmic Femtosecond Lasers Market industry. Cataract is the leading cause of serious vision impairment in emerging economies. The World Health Organization conducted a population-based prevalence assessment for blindness across diverse African regions that are not endemic for trachoma or onchocerciasis, and found a blindness rate of roughly 1%, with cataract accounting for 40% to 50% of visual loss cases.

Comments